Drugs belonging to class 'Nucleoside analog reverse transcriptase inhibitor'

See adverse reactions attributed to class 'Nucleoside analog reverse transcriptase inhibitor'

Drug NameCompare
Abacavircompare
Bictegravir/Emtricitabine/Tenofovir Alafenamidecompare
Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamidecompare
Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxilcompare
Didanosinecompare
Emtricitabinecompare
Emtricitabine/Rilpivirine/Tenofovir Alafenamidecompare
Lamivudinecompare
Stavudinecompare
Telbivudinecompare
Tenofovir Disoproxilcompare
Zalcitabinecompare
Zidovudinecompare

 

Adverse reactions attributed to entire drug class 'Nucleoside analog reverse transcriptase inhibitor'

Please login to view adverse reactions

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top